The global veterinary anthrax vaccines market is expected to grow at a CAGR of 5.5% during the forecast period, to reach USD 1.2 billion by 2030. The growth of this market is driven by the increasing demand for livestock and poultry products in emerging economies such as China and India, which are witnessing rapid economic growth and urbanization. In addition, the growing awareness about animal welfare has led to an increase in demand for animal vaccines across the globe.
Cell free PA vaccines segment accounted for over 50% share of the global veterinary anthrax vaccines market in 2017 owing to their advantages such as ease of administration, low cost per dose, and high efficacy rates against anthrax infection among animals. Live vaccine segment is expected to grow at a CAGR of 6% during the forecast period due to its advantages such as long-lasting immunity against anthrax infection among animals and ability to induce protective antibodies against other diseases that may be present in an animal’s environment or herd/flock population.
- Increasing awareness about animal welfare and food safety is also expected to fuel the growth of this market in coming years.
- The rising demand for meat products in developing countries such as China and India is also expected to drive the growth of this market in coming years due to increased consumption levels among consumers in these regions.
Industry Growth Insights published a new data on “Veterinary Anthrax Vaccines Market”. The research report is titled “Veterinary Anthrax Vaccines Market research by Types (Cell Free PA Vaccines, Live Vaccines), By Applications (Cow, Sheep, Swine, Other), By Players/Companies Agrovet, Bayer Sanidad Animal, Biogenesis Bago SA, Botswana Vaccine Institute, Central Veterinary Control and Research Institute, Centro Diagnostico Veterinario, Ceva Sante Animale, Colorado Serum Company, Empresa Colombiana de Productos Veterinarios S.A, Indian Immunologicals Limited, Institute for Biological Products, Intervac (PVT) Ltd, JOVAC”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Veterinary Anthrax Vaccines Market Research Report
By Type
Cell Free PA Vaccines, Live Vaccines
By Application
Cow, Sheep, Swine, Other
By Companies
Agrovet, Bayer Sanidad Animal, Biogenesis Bago SA, Botswana Vaccine Institute, Central Veterinary Control and Research Institute, Centro Diagnostico Veterinario, Ceva Sante Animale, Colorado Serum Company, Empresa Colombiana de Productos Veterinarios S.A, Indian Immunologicals Limited, Institute for Biological Products, Intervac (PVT) Ltd, JOVAC
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Veterinary Anthrax Vaccines Market Report Segments:
The global Veterinary Anthrax Vaccines market is segmented on the basis of:
Types
Cell Free PA Vaccines, Live Vaccines
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cow, Sheep, Swine, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Agrovet
- Bayer Sanidad Animal
- Biogenesis Bago SA
- Botswana Vaccine Institute
- Central Veterinary Control and Research Institute
- Centro Diagnostico Veterinario
- Ceva Sante Animale
- Colorado Serum Company
- Empresa Colombiana de Productos Veterinarios S.A
- Indian Immunologicals Limited
- Institute for Biological Products
- Intervac (PVT) Ltd
- JOVAC
Highlights of The Veterinary Anthrax Vaccines Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cell Free PA Vaccines
- Live Vaccines
- By Application:
- Cow
- Sheep
- Swine
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Veterinary Anthrax Vaccines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Veterinary anthrax vaccines are used to protect animals from anthrax infection. Anthrax is a serious, potentially fatal disease caused by the bacterium Bacillus anthracis. Anthrax can be contracted through contact with infected animal or human tissue, contaminated soil, or water. Symptoms ofAnthrax include fever, chest pain, shortness of breath, and swelling in the lungs. If left untreated, Anthrax can lead to death. Veterinary anthrax vaccines help protect animals from contracting this deadly disease.
Some of the major players in the veterinary anthrax vaccines market are Agrovet, Bayer Sanidad Animal, Biogenesis Bago SA, Botswana Vaccine Institute, Central Veterinary Control and Research Institute, Centro Diagnostico Veterinario, Ceva Sante Animale, Colorado Serum Company, Empresa Colombiana de Productos Veterinarios S.A, Indian Immunologicals Limited, Institute for Biological Products, Intervac (PVT) Ltd, JOVAC.
The veterinary anthrax vaccines market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Veterinary Anthrax Vaccines Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Veterinary Anthrax Vaccines Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Veterinary Anthrax Vaccines Market - Supply Chain
4.5. Global Veterinary Anthrax Vaccines Market Forecast
4.5.1. Veterinary Anthrax Vaccines Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Veterinary Anthrax Vaccines Market Size (000 Units) and Y-o-Y Growth
4.5.3. Veterinary Anthrax Vaccines Market Absolute $ Opportunity
5. Global Veterinary Anthrax Vaccines Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Veterinary Anthrax Vaccines Market Size and Volume Forecast by Type
5.3.1. Cell Free PA Vaccines
5.3.2. Live Vaccines
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Veterinary Anthrax Vaccines Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Veterinary Anthrax Vaccines Market Size and Volume Forecast by Application
6.3.1. Cow
6.3.2. Sheep
6.3.3. Swine
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Veterinary Anthrax Vaccines Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Veterinary Anthrax Vaccines Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Veterinary Anthrax Vaccines Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Veterinary Anthrax Vaccines Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Veterinary Anthrax Vaccines Demand Share Forecast, 2019-2026
9. North America Veterinary Anthrax Vaccines Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Veterinary Anthrax Vaccines Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Veterinary Anthrax Vaccines Market Size and Volume Forecast by Application
9.4.1. Cow
9.4.2. Sheep
9.4.3. Swine
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Veterinary Anthrax Vaccines Market Size and Volume Forecast by Type
9.7.1. Cell Free PA Vaccines
9.7.2. Live Vaccines
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Veterinary Anthrax Vaccines Demand Share Forecast, 2019-2026
10. Latin America Veterinary Anthrax Vaccines Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Veterinary Anthrax Vaccines Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Veterinary Anthrax Vaccines Market Size and Volume Forecast by Application
10.4.1. Cow
10.4.2. Sheep
10.4.3. Swine
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Veterinary Anthrax Vaccines Market Size and Volume Forecast by Type
10.7.1. Cell Free PA Vaccines
10.7.2. Live Vaccines
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Veterinary Anthrax Vaccines Demand Share Forecast, 2019-2026
11. Europe Veterinary Anthrax Vaccines Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Veterinary Anthrax Vaccines Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Veterinary Anthrax Vaccines Market Size and Volume Forecast by Application
11.4.1. Cow
11.4.2. Sheep
11.4.3. Swine
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Veterinary Anthrax Vaccines Market Size and Volume Forecast by Type
11.7.1. Cell Free PA Vaccines
11.7.2. Live Vaccines
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/GrowthPotential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Veterinary Anthrax Vaccines Demand Share, 2019-2026
12. Asia Pacific Veterinary Anthrax Vaccines Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Veterinary Anthrax Vaccines Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Veterinary Anthrax Vaccines Market Size and Volume Forecast by Application
12.4.1. Cow
12.4.2. Sheep
12.4.3. Swine
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Veterinary Anthrax Vaccines Market Size and Volume Forecast by Type
12.7.1. Cell Free PA Vaccines
12.7.2. Live Vaccines
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Veterinary Anthrax Vaccines Demand Share, 2019-2026
13. Middle East & Africa Veterinary Anthrax Vaccines Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Veterinary Anthrax Vaccines Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Veterinary Anthrax Vaccines Market Size and Volume Forecast by Application
13.4.1. Cow
13.4.2. Sheep
13.4.3. Swine
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Veterinary Anthrax Vaccines Market Size and Volume Forecast by Type
13.7.1. Cell Free PA Vaccines
13.7.2. Live Vaccines
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Veterinary Anthrax Vaccines Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Veterinary Anthrax Vaccines Market: Market Share Analysis
14.2. Veterinary Anthrax Vaccines Distributors and Customers
14.3. Veterinary Anthrax Vaccines Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Agrovet
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Bayer Sanidad Animal
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Biogenesis Bago SA
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Botswana Vaccine Institute
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Central Veterinary Control and Research Institute
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Centro Diagnostico Veterinario
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Ceva Sante Animale
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Colorado Serum Company
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Empresa Colombiana de Productos Veterinarios S.A
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Indian Immunologicals Limited
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Institute for Biological Products
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Intervac (PVT) Ltd
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. JOVAC
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
